Nobody likes talking about it, but up to 5 percent of all men and women in Germany are affected by weak bowel closure. And yet this condition, medically known as anal incontinence, remains a taboo topic in public. How can patients be treated successfully?
According to current research, the Triple Target Treatment (3T) with the PROCOM Contrain® continence trainer has proven particularly effective. In clinical studies, more than 80 percent of patients were able to completely control their bowel closure or achieved significant improvements after treatment with Contrain®.
What makes treatment with Contrain® so successful?
To seal the rectum, besides muscles in the anus, humans have a so-called kink closure whose musculature can be specifically targeted. Therefore, treatment with Contrain® doesn't just strengthen the closing musculature and the base of the pelvis; Contrain® also trains the puborectalis muscle deep in the abdomen, which provides the pulling force for the kink closure.
This can be achieved with pain-free and deep-acting middle frequency stimulation for which Contrain® has been specifically developed and produced. The Contrain® device stimulation is tolerated extremely well and is virtually free of side effects. The 3T treatment also equalizes the nerve coordination deficit between the brain and the continence muscles.
More than ten thousand patients with fecal incontinence, urinary incontinence or constipation have already markedly improved their quality of life with Contrain®.